Psychological Intervention in an Integrated Health Care Service for Children with Atopic Dermatitis

아토피피부염 통합치료 프로그램에서의 심리적 개입의 실제

  • 조성은 (서울특별시 서울의료원 아토피클리닉) ;
  • 전지은 (서울특별시 서울의료원 아토피클리닉) ;
  • 조하나 (서울특별시 서울의료원 아토피클리닉) ;
  • 손동국 (서울특별시 서울의료원 아토피클리닉) ;
  • 김혜원 (서울특별시 서울의료원 아토피클리닉) ;
  • 이수형 (서울특별시 서울의료원 아토피클리닉) ;
  • 염혜영 (서울특별시 서울의료원 아토피클리닉)
  • Received : 2009.10.14
  • Accepted : 2010.04.23
  • Published : 2010.06.25

Abstract

Background: Psychological interventions have potentials for improving disease management and quality of life in children with atopic dermatitis (AD) and their families. However, integration of medical and psychological health care in the treatment of children with AD is very rare in Korea. Objective: The aim of this study was to present descriptive data from a hospital-based interdisciplinary program that provides integrated medical and psychological health-care for children with AD. Method: Clinical records were reviewed for 127 children seen in our program as well as common problems and interventions addressed during family visits with the program psychologist. Age group differences in problems and interventions addressed during psychology sessions were evaluated. Also, the differences by symptom severity and sex in problems addressed during psychology sessions were analyzed. Result: Significant age-group differences were found in the problems and interventions addressed during psychology sessions. Among the age groups, sleep problems were most common in the <5 age group (50.0%). Negative self-image, problems of being bullied and attention problems were most common in the 6~12 age group (25.4%, 23.7% and 16.9%, respectively). Anxious/depressed mood, study burden and parent-child relational problems were most common in the 13~18 age group (65.0%, 60.0% and 45.0% respectively). Conclusion: The results of this study support the need for and feasibility of providing integrated care for children with AD and their families. Age-group differences found in problems and interventions addressed during psychology sessions could be useful especially in planning for group sessions.

Keywords

References

  1. William HC, Robertson CF, Stewart AW on behalf of the ISAAC Steering Committee. Worldwide variations in the prevalence of atopic eczema symptoms. J Allergy Clin Immunol 1999;103: 125-38 https://doi.org/10.1016/S0091-6749(99)70536-1
  2. Diepgen TL: Is the prevalence of atopic dermatitis increasing, In Williams HC(ed.): Epidemiology of atopic eczema. p 96-109, Cambridge University Press, Cambridge, 2000
  3. Raimer SS. Managing pediatric atopic dermatitis. Clin Pediatr 2000;39:1-14 https://doi.org/10.1177/000992280003900101
  4. Kodama A, Horikawa T, Suzuki T, Ajiki W, Takashima T, Harada S. Effect of stress on atopic dermatitis: investigation in patients after the Great Hanshin Earthquake. J Allergy Clin Immunol 1999;104:173-6 https://doi.org/10.1016/S0091-6749(99)70130-2
  5. King RM, Wilson GV. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res 1991;35:697-706 https://doi.org/10.1016/0022-3999(91)90120-D
  6. Helmbold P, Gaisbauer G, Kupfer J, Haustein UF. Longitudinal case analysis in atopic dermatitis. Acta Derm Venereol 2000; 80:348-52 https://doi.org/10.1080/000155500459286
  7. Gieler U, Volker N, Burkhard B: Psychoimmnology and evaluation of therapeutic approaches, In Bieber T, Leung DYM (eds.): Atopic dermatitis. p 43-66, Marcel Dekker Inc., New York, 2002
  8. Kiecolt-Glaser JK. Stress, personal relationships, and immune functions: health implications. Brain Behav Immunol 1999;13: 61-71 https://doi.org/10.1006/brbi.1999.0552
  9. Persoons JH, Berkenbosch F, Schornagel K, Thepen T, Kraal G. Increased specific IgE production in lungs after the induction of acute stress in rats. J Allergy Clin Immunol 1995;95:765-70 https://doi.org/10.1016/S0091-6749(95)70184-2
  10. Singh LK, Alexacos N, Letourneau R, Theoharides TC. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders. Brain Behav Immunol 1999;13: 225-39 https://doi.org/10.1006/brbi.1998.0541
  11. Goebel MU, Mills PJ. Acute psychological stress and exercise and changes in the peripheral leukocyte adhesion molecule expression and density. Psychosom Med 2000;62:664-70
  12. Paik IH, Toh KY, Lee C, Kim JJ, Lee SJ. Psychological stress may induce increased humoral and decreased cellular immunity. Behav Med 2000;26:139-41 https://doi.org/10.1080/08964280009595761
  13. Schmid-Ott G, Jaeger B, Adamek C, Koch H, Lamprecht F, Kapp A. Levels of circulating CD 8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol 2001;107:171-7 https://doi.org/10.1067/mai.2001.111850
  14. Chamlin SL, Friedman IJ, Williams ML, Chren M. Effects of atopic dermatitis on young American children and their families. Pediatrics 2004;114:607-11 https://doi.org/10.1542/peds.2004-0374
  15. Kim K. Management of sleep disturbance associated with atopic dermatitis. J Allergy Clin Immunol 2006;118:198-201 https://doi.org/10.1016/j.jaci.2006.04.038
  16. Dahl RE, Bernhisel-Broadbent J, Scanlong-Holdford S, Sampson HA, Lupo M. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995;149:856-60 https://doi.org/10.1001/archpedi.1995.02170210030005
  17. Paller AS, McAlister RO, Doyle JJ, Jackson A. Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment. Clin Pediatr 2002;41:323-32. https://doi.org/10.1177/000992280204100505
  18. Lewis-Jones MS, Finlay AY. The children"fs dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol 1995;132:942-9
  19. Howlett S. Emotional dysfunction, child-family relationships and childhood atopic dermatitis. Br J Dermatol 1999;140:381-4 https://doi.org/10.1046/j.1365-2133.1999.02696.x
  20. Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997; 76:159-62 https://doi.org/10.1136/adc.76.2.159
  21. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the dermatitis family impact questionnaire. Br J Dermatol 1998;138:107-13 https://doi.org/10.1046/j.1365-2133.1998.02034.x
  22. Melin L, Fredriksen T, Noren P, Swelbilius BG. Behavioural treatment of scratching in patients with atopic dermatitis. Br J Dermatol 1986;115:467-74 https://doi.org/10.1111/j.1365-2133.1986.tb06241.x
  23. Noren P, Melin L. The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis. Br J Dermatol 1989;121:359-66 https://doi.org/10.1111/j.1365-2133.1989.tb01430.x
  24. Ehlers A, Stangier U, Gieler U. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol 1995;63:624-35
  25. Habib S, Morrissey S. Sress management for atopic dermatitis. Behav Change 1999;16:226-36 https://doi.org/10.1375/bech.16.4.226
  26. Linnet J, Jemec GBE. Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients. Int J Dermatol 2001;40:632-6 https://doi.org/10.1046/j.1365-4362.2001.01272.x
  27. Staab D, von Rueden U, Khert R, Erhart M, Wenninger K, Kamtsiuris P, et al. Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol 2002;13:84-90 https://doi.org/10.1034/j.1399-3038.2002.01005.x
  28. Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-corzilius T, Ring J, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multi-centre, randomized controlled trial. BMJ 2006;332:932-8
  29. Walders N, Drotar D. Integrating health and mental health services in the care of children and adolescents with chronic health conditions: assumptions, challenges, and opportunities. Child Serv Soc Pol Res Pract 1999;2:117-38
  30. European Task Force on Atopic Dermatitis. Severity Scoring of Atopic Dermatitis: The SCORAD index. Consensus report of the European task force on atopic dermatitis. Dermatology 1993; 186:23-31 https://doi.org/10.1159/000247298
  31. Pyun BY: A study for the quality of life and financial burden of patients and their families with atopic disease, In Kwon HJ(ed.): Atopic disease prevalence & epidemiology study: Atopy free seoul project. p100-114, Atopy Research Institute, Seoul, 2008
  32. Shin NL, Kim SH, Cho SY, Whang KK, Hahm JH. The impact of childhood atopic dermatitis on their families. Korean J Dermatol 2000;38:494-9
  33. LeBovidge JS, Kelley SD, Lauretti A, Bailey EP, Timmons KG, Tommons AK, et al. Integrating Medical and Psychological Health Care for Children with Atopic Dermatitis. J Pediatr Psychol 2007;32:617-25
  34. Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004;150:284-90 https://doi.org/10.1111/j.1365-2133.2004.05776.x
  35. Hon KL, Kam WY, Lam MC, Leung TF. CDLQI, scorad and ness: are they correlated? Qual Life Res 2006;15:1551-8 https://doi.org/10.1007/s11136-006-0019-7
  36. Balkrishnan R, Housman TS, Carrol C, Feldman SR, Fleischer AB. Disease severity and associated family impact in childhood atopic dermatitis. Arch Dis Child 2003;88:423-7 https://doi.org/10.1136/adc.88.5.423
  37. Carson DK, Swanson DM, Cooney MH, Gillum BJ, Cuningham D. Stress and coping as predictors of young children's development and psychosocial adjustment. Child Stud J 1992; 22:273-302
  38. Compas BE, Malcarne VL, Fondacaro KM. Coping with stressful events in older children and young adolescents. J Consult Clin Psychol 1988;56:405-11